1. Home
  2. MLCO vs LMAT Comparison

MLCO vs LMAT Comparison

Compare MLCO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$5.45

Market Cap

2.2B

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$101.30

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCO
LMAT
Founded
2003
1983
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
MLCO
LMAT
Price
$5.45
$101.30
Analyst Decision
Buy
Buy
Analyst Count
5
5
Target Price
$10.10
$105.80
AVG Volume (30 Days)
3.2M
347.2K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
0.93%
EPS Growth
N/A
30.57
EPS
N/A
0.68
Revenue
N/A
$249,602,000.00
Revenue This Year
$5.42
$14.21
Revenue Next Year
$4.37
$8.88
P/E Ratio
$12.16
$151.57
Revenue Growth
N/A
13.53
52 Week Low
$5.07
$79.01
52 Week High
$10.15
$118.01

Technical Indicators

Market Signals
Indicator
MLCO
LMAT
Relative Strength Index (RSI) 51.76 55.25
Support Level $5.18 $82.47
Resistance Level $5.71 $114.98
Average True Range (ATR) 0.20 3.52
MACD 0.02 0.32
Stochastic Oscillator 69.23 63.26

Price Performance

Historical Comparison
MLCO
LMAT

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: